Alcon showcases new data at APACRS 2025, emphasizing advancements in IOL technology and surgical precision for improved ...

We recently published 10 Stocks Crash as AI Glow Fades. Alcon Inc. (NYSE:ALC) is one of Wednesday’s worst performers. Shares of Alcon Inc. snapped a six-day winning streak on Wednesday, losing 10.07 ...

Tom McDonald worked at Alcon for nearly four decades and writes about the eyecare giant's remarkable growth that started in ...

ALC's Q2 earnings top estimates but revenues fall short, sending shares down more than 10% as margins tightened and 2025 sales outlook narrowed.

Alcon (NYSE:ALC) stock continues to decline as J.P. Morgan downgrades the company following mixed Q2 2025 results and lowered sales guidance. Read more here.

Alcon affirmed fiscal year 2025 adjusted earnings of $3.05-$3.15 versus consensus of $3.12. The company lowered 2025 sales guidance from $10.4 billion-$10.5 billion to $10.3 billion-$10.4 billion, ...

The analysts cut its rating on Alcon shares to “neutral” from “overweight” and lowered its price target to SFr 62.8 for June 2027, down from SFr 94.7 for June 2026. The reduced target reflects lower ...

Alcon India unveils UNITY VCS and UNITY CS with superior efficiency for vitreoretinal and cataract surgery: Our Bureau, Bengaluru Thursday, August 21, 2025, 14:40 Hrs [IST] Alcon, ...

Alcon AG (NYSE:ALC) saw its stock fall more than 2% on Thursday following a rating cut by J.P. Morgan, citing disappointing ...

Aegon (NYSE: AEG) ADRs rose 5.5% after the Dutch insurer doubled the planned value of its ongoing share buyback program, which it aims to conclude by the end of 2025, and said it was studying the ...

The initial impact of President Donald Trump's new tariffs has been quite muted, but the reason lies more in how companies have responded rather than in the policy, Mohamed El-Erian, Allianz chief ...

Kite Pharma is acquiring Interius BioTherapeutics for $350 million, adding in vivo CAR T technology that could simplify treatment and expand patient access.